Join us at 4pm BST on the 27th April for the third episode in our four-part series on Cancer Research, with Prof Chris Bakal, Institute of Cancer Research. In the period 7th April-29th April, Researcher Live will feature exclusive sessions on innovations and advancements in cancer research, spotlighting experts in the field. Sign up here to receive email updates about this series.
  • 7th April, 10am BST - Prof Ann Ager, Cardiff University: 'T cell homing in cancer immunotherapy: challenges and opportunities'


  • 21st April, 10am BST - Dr Luke Tattersall, University of Sheffield: ‘Preclinical bone cancer research’


  •  27th April, 4pm BST - Prof Chris Bakal, Institute of Cancer Research: ‘The shape of you: Using AI, bioengineering, and statistical cell biology to understand how changes in cell morphogenesis drives cancer’


  • 29th April, 4pm BST- Prof Dean Fennell, University of Leicester: ‘Mesothelioma. The evolving treatment landscape and future directions’


The one consistent hallmark of cancer is that tumour cells have radically different shapes compared to those of normal cells. These shape changes are essential to drive tumour cell division and metastasis. Moreover, the shape of a tumour cell determines the response to therapy. However, we have little understanding of the complex relationship between cell shape and cancer.
In this third sesseion, Prof Chris Bakal will discuss how his lab is using integrative technologies to describe signalling networks that link cancer to shape, and how these networks can be targetted therapeutically.  


To speak at a Researcher Live session, please email kristine.lennie@researcher-app.com 


Follow the Researcher Live's 'Strides in Cancer Research' profile for updates on the series, by clicking here.

Date and Time
Wednesday, April 27, 2022 3:00 PM 03:00 pm - 04:00 pm GMT+0
Speakers Avatar Prof Chris Bakal, Institute of Cancer Research

Prof Chris Bakal studies the biological switches that cause cells to change shape, become cancerous and spread around the body. Prof Bakal is Leader of the Dynamical Cell Systems Team within the Division of Cancer Biology at the The Institute of Cancer Research. Prof Bakal’s team aims to understand how normal and cancerous cells can adopt different shapes and why metastatic cancer develops in some people but not others.


Prof Bakal received his PhD in Medical Biophysics at the University of Toronto and the Ontario Cancer Institute. He joined Harvard Medical School and the Howard Hughes Medical Institute as a postdoctoral fellow in 2004. In 2006, he also became an affiliate of the Computer Science and Artificial Intelligence Laboratory (CSAIL) at the Massachusetts Institute of Technology, as well as an affiliate of the Broad Institute. He devised an automated computer programme used to recognise the shape of cells and infer the corresponding genetic alterations that have occurred in the cell.


Prof Bakal has received several awards including the Dorsett L. Spurgeon Award in 2007 as the top postdoctoral fellow at Harvard Medical School. In 2009, he received an Outstanding Research Award from Nature Biotechnology. 

DOI: EFa49AM7iaPuCIiklhta_prepost_1

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.